Donald Trump’s new commercial offensive has already caused a billionaire freezing in market operations in less than 24 hours, reaching initial public acquisitions, acquisitions and offers (IPOS) around the world.
Companies such as StubHub Ticket Platform, Fintech of Payments Klarna, Adtech MNTN and Insurer Tempregrity decided to suspend capital opening plans, according to sources heard by Bloomberg. Decisions were made after the markets recorded sharp losses with Trump’s announcement on Wednesday (2) to impose the most aggressive US tariffs in a century.
An IPOS sector executive stated that all offers should be postponed for at least two weeks, with low expectations that companies start roadshows to investors in the face of current volatility.
Fintech Chime also postponed the sending of regulatory documents, postponing its IPO, according to the Wall Street Journal.
The impact goes beyond bags and already affects the mergers and acquisition market. French Saint-Gobain decided to suspend the sale of its automotive glass unit, an operation that could raise up to $ 2.8 billion. Already the manager KKR abandoned a consortium that negotiated the purchase of German Gerresheimer, manufacturer of packaging for the pharmaceutical and cosmetic industry, evaluated at about € 2 billion.
Business already agreed are also at risk. In leveraged debt markets, emissions to finance purchases such as Canadian Converge Technology Solutions by Hig Capital and the acquisition of IT Fluid Systems by ABC Technologies were postponed.
Continues after advertising
Retaliation and uncertainties
Trump’s rates announced immediately retaliation. About all American products, besides restricting rare land exports. The European Union, the largest commercial partner in the US, also promised to react. .
The movement represents a new thud for bankers and negotiators, who bet on a strong year for the “Trump 2.0” capital market. The global M&A activity was already weak in the first quarter, and the fear that the long -awaited Ipos would end up locked.
Some transactions were already being affected. Interested in the home care assets of Reckitt Benckiser were reevaluating the impact of tariffs. Court Square Capital Partners has given up the sale of Golden State Medical Supply, a supplier of the US health system, due to uncertainties. British Rosebank Industries canceled a purchase of $ 2 billion citing volatility. The list of € 1.5 billion of the German pharmacist STADA Arzneimittel was also postponed.
Continues after advertising
©2025 Bloomberg L.P.
